Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.36 |
| ▸ | ODC1 | P11926 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15108551 | 1.00 | NPC1 (0.48) | NPC1SIGMAR1NAAAODC1CA1 | |
| SCHEMBL29291655 | 0.98 | NPC1 (0.45) | NPC1SIGMAR1NAAAODC1CA1 | |
| SCHEMBL8060908 | 0.93 | NPC1 (0.47) | NPC1SIGMAR1NAAACA1CA2 | |
| SCHEMBL26288724 | 0.93 | — | — | |
| SCHEMBL20233658 | 0.91 | SIGMAR1 (0.48) | NPC1SIGMAR1NAAACA1CA2 | |
| SCHEMBL26126847 | 0.91 | SIGMAR1 (0.48) | NPC1SIGMAR1NAAACA1CA2 | |
| SCHEMBL653814 | 0.87 | ODC1 (0.41) | NPC1SIGMAR1ODC1CA1CA2 | |
| SCHEMBL1734731 | 0.85 | NPC1 (0.52) | NPC1SIGMAR1NAAACA1CA2 | |
| SCHEMBL9011558 | 0.85 | NPC1 (0.56) | NPC1NAAACA1CA2EPHX1 | |
| SCHEMBL1860292 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-60262893-A | — | — | None | — | — | JP | disclosed |
| JP-62041293-A | — | — | None | — | — | JP | disclosed |
| US-20250215116-A1 | ONIUM SALT, ONIUM SALT COMPOSITION, LIQUID COMPOSITION CONTAINING ONIUM SALT AND POLYSACCHARIDE AND PRODUCTION METHOD THEREOF, AND METHOD FOR RECOVERING POLYSACCHARIDE | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2025-07-03 | — | — | US | disclosed |
| US-20250109090-A1 | METHOD FOR PRODUCING ONIUM SALT AND METHOD FOR PURIFYING ONIUM SALT | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2025-04-03 | — | — | US | disclosed |
| EP-4530284-A1 | METHOD FOR PRODUCING ONIUM SALT AND METHOD FOR PURIFYING ONIUM SALT | Koei Chemical Company, Limited (JP) | 2025-04-02 | — | — | EP | disclosed |
| CN-119707822-A | Method for producing onium salt and method for purifying onium salt | 广荣化学株式会社 | 2025-03-28 | — | — | CN | disclosed |
| EP-4501914-A1 | ONIUM SALT, ONIUM SALT COMPOSITION, LIQUID COMPOSITION CONTAINING ONIUM SALT AND POLYSACCHARIDE AND PRODUCTION METHOD THEREOF, AND METHOD FOR RECOVERING POLYSACCHARIDE | Koei Chemical Company, Limited (JP) | 2025-02-05 | — | — | EP | disclosed |
| US-20250034600-A1 | ONIUM SALT COMPOSITIONS, METHODS FOR PRODUCING CELLULOSE HYDROLYSATES, ALCOHOLS AND/OR ORGANIC ACIDS IN THE PRESENCE OF ONIUM SALT COMPOSITIONS | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2025-01-30 | — | — | US | disclosed |
| EP-4497830-A1 | ONIUM SALT COMPOSITIONS, METHODS FOR PRODUCING CELLULOSE HYDROLYSATES, ALCOHOLS AND/OR ORGANIC ACIDS IN THE PRESENCE OF ONIUM SALT COMPOSITIONS | Koei Chemical Company, Limited (JP) | 2025-01-29 | — | — | EP | disclosed |
| CN-119372264-A | Onium salt composition, method for producing cellulose hydrolysate, and method for producing alcohol and/or organic acid | 广荣化学株式会社 | 2025-01-28 | — | — | CN | disclosed |
| EP-0711760-A1 | METHOD OF ALKYLATING TRIAZINE DERIVATIVE | NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) | 1996-05-15 | — | — | EP | disclosed |
| US-4995997-A | Containing aromatic amine | YUSHIRO CHEMICAL INDUSTRY CO., LTD. (JP) | 1991-02-26 | — | — | US | disclosed |
| EP-0388320-A1 | Antibacterial water-soluble cutting fluids resistant to yeast-like fungi | YUSHIRO CHEMICAL INDUSTRY CO. LTD. (JP) | 1990-09-19 | — | — | EP | disclosed |
| JP-S6241293-A | AGENT AND METHOD FOR PREVENTING SLIME OCCURRENCE IN LUBRICANT | KAWASAKI STEEL CORP | 1987-02-23 | — | — | JP | disclosed |
| JP-S60262893-A | WATER-SOLUBLE CUTTING OIL | YUSHIRO DO BRAZIL IND CHEM LTD | 1985-12-26 | — | — | JP | disclosed |
| US-4249003-A | Process for polycyclic amines | AKTIEBOLAGET LEO (SE) | 1981-02-03 | — | — | US | disclosed |
| US-4249002-A | Polycyclic amines and intermediates therefor | AKTIEBOLAGET LEO (SE) | 1981-02-03 | — | — | US | disclosed |
| US-4045424-A | Salt of a sulfonic acid substituted 1:2 metal complex dye with a basic dye and an amine | BASF AKTIENGESELLSCHAFT (DT) | 1977-08-30 | — | — | US | disclosed |
| US-4027037-A | ARTHROPOD METAMORPHOSIS INHIBITORS | BAYER AKTIENGESELLSCHAFT (DT) | 1977-05-31 | — | — | US | disclosed |
| JP-S06241293-A | — | — | 0001-01-01 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250109090-A1 | METHOD FOR PRODUCING ONIUM SALT AND METHOD FOR PURIFYING ONIUM SALT | NOTUM, CA7, CROCC | NPC1 1753/4885SIGMAR1 2919/4885NAAA 76/4885 |
| US-20250034600-A1 | ONIUM SALT COMPOSITIONS, METHODS FOR PRODUCING CELLULOSE HYDROLYSATES, ALCOHOLS AND/OR ORGANIC ACIDS IN THE PRESENCE OF ONIUM SALT COMPOSITIONS | ADH5, ADH1C, AMY1A | NPC1 3775/4885SIGMAR1 2083/4885NAAA 358/4885 |
| US-20250215116-A1 | ONIUM SALT, ONIUM SALT COMPOSITION, LIQUID COMPOSITION CONTAINING ONIUM SALT AND POLYSACCHARIDE AND PRODUCTION METHOD THEREOF, AND METHOD FOR RECOVERING POLYSACCHARIDE | ALG1, FUT5, NANS | NPC1 1545/4885SIGMAR1 2459/4885NAAA 1244/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.